{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:35:18Z","timestamp":1788348918313,"version":"build-2803163510"},"reference-count":34,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2008,5,23]],"date-time":"2008-05-23T00:00:00Z","timestamp":1211500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2008,8]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> The objective was the evaluation of the effect of the Dutch national routine antenatal RhIG (anti\u2010D) immunization prevention (RAADP) program comprising one single dose of 200\u2003\u03bcg (1000\u2003IU) of RhIG in the 30th week of pregnancy, restricted to women without a living child.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> A nationwide historic control study was performed. All newly detected anti\u2010D\u2013immunized para\u20101 in 1999, 2002, and 2004 were included and classified on the basis of received prophylaxis during the first pregnancy: antenatal and postnatal versus only postnatal RhIG. The numbers of D\u2013 parae\u20101 who delivered a D+ first child before the introduction (control group) or after the introduction (intervention group) of the RAADP were calculated from Vital Birth Statistics (8,700 and 12,000, respectively).<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> Fifty\u2010eight newly detected anti\u2010D immunizations in the first trimester were observed in the control group and 39 in the intervention group, which resulted in a significant reduction of the prevalence of new anti\u2010D immunizations from 0.67\u2003percent (95% confidence interval [CI], 0.50%\u20100.84%) to 0.31\u2003percent (95% CI, 0.21%\u20100.41%). No reduction was observed in anti\u2010D immunizations newly detected at the 30th\u2010week screening (0.25%). A nonsignificant risk reduction of the risk of severe hemolytic disease of the fetus and newborn (HDFN) was found (0.23% vs. 0.10%). The numbers needed to treat to prevent one anti\u2010D\u2013immunized pregnancy and one case of subsequent severe HDFN were 357 and 1255, respectively.<\/jats:p><jats:p><jats:bold>CONCLUSIONS:<\/jats:bold> RAADP of one single dose of 200\u2003\u03bcg of RhIG in addition to postnatal RhIG (200\u2003\u03bcg) halves the risk of anti\u2010D immunization and subsequent severe HDFN.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2008.01742.x","type":"journal-article","created":{"date-parts":[[2008,5,23]],"date-time":"2008-05-23T18:11:03Z","timestamp":1211566263000},"page":"1721-1729","source":"Crossref","is-referenced-by-count":107,"title":["One single dose of 200\u2003\u03bcg of antenatal RhIG halves the risk of anti\u2010D immunization and hemolytic disease of the fetus and newborn in the next pregnancy"],"prefix":"10.1111","volume":"48","author":[{"given":"Joke M.","family":"Koelewijn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masja","family":"De Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja G.M.","family":"Vrijkotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gouke J.","family":"Bonsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Ellen","family":"Van Der Schoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,29]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199812103392410"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1939.72800270002007a"},{"key":"e_1_2_7_4_2","first-page":"390","volume-title":"Blood transfusion in clinical medicine","author":"Mollison PL","year":"1997"},{"key":"e_1_2_7_5_2","first-page":"21","volume-title":"Alloimmune disorders of pregnancy","author":"Daniels G","year":"2002"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.00924_1.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1054\/blre.1999.0123"},{"key":"e_1_2_7_8_2","first-page":"50","volume-title":"Prevention of pregnancy immunization","author":"Committee prevention pregnancy immunization.","year":"1992"},{"key":"e_1_2_7_9_2","unstructured":"BowmanJM ChownB LewisM PollockJM.Rh isoimmunization during pregnancy: antenatal prophylaxis.Can Med Assoc1978 623\u20107."},{"key":"e_1_2_7_10_2","first-page":"627","article-title":"Antenatal prophylaxis of Rh isoimmunization: 28\u2010weeks'\u2010gestation service program","volume":"118","author":"Bowman JM","year":"1978","journal-title":"Can Med Assoc J"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90232-5"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016348409157011"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-7963(87)70010-8"},{"key":"e_1_2_7_14_2","first-page":"101","article-title":"Ante\u2010partum administration of preventive treatment of Rh\u2010D immunization in rhesus\u2010negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region","volume":"16","author":"Huchet J","year":"1987","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016348909087688"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.298.6689.1671"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.1995.tb00180.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7122.1588"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1999.tb08304.x"},{"key":"e_1_2_7_20_2","doi-asserted-by":"crossref","unstructured":"CrowtherCA MiddletonP.Anti\u2010D administration in pregnancy for preventing rhesus alloimmunisation.Cochrane Database Syst Rev2000;(2):CD000021. DOI: 10.1002\/14651858.CD000021.","DOI":"10.1002\/14651858.CD000020"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta7040"},{"key":"e_1_2_7_22_2","first-page":"328","article-title":"Current status of immunoprophylaxis with anti\u2010D immunoglobin","volume":"85","author":"Engelfriet CP","year":"2003","journal-title":"Vox Sang"},{"key":"e_1_2_7_23_2","unstructured":"Committee prevention pregnancy immunization. Prevention of pregnancy immunization. The Hague:Dutch Health Council;1992;1992\/08:56\u20107[Report in Dutch]."},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7144.1611"},{"key":"e_1_2_7_25_2","volume-title":"Pregnancy immunization, hepatitis B and lues.","author":"Council of Health Insurances.","year":"1998"},{"key":"e_1_2_7_26_2","volume-title":"Guide line blood transfusion","author":"Quality Institute of Healthcare and evidence\u2010based guideline development (CBO).","year":"2004"},{"key":"e_1_2_7_27_2","volume-title":"Process monitoring pre\u2010 and postnatal screenings 2003","author":"Ploeg CPB vd","year":"2006"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(05)80053-8"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2001.112970"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052855"},{"key":"e_1_2_7_31_2","unstructured":"Statistics Netherlands. Available at:http:\/\/statline.cbs.nl\/StatWeb\/publication\/?DM=SLNL&PA=37744NED&D1=0\u201015&D2=0&D3=(1\u201011)\u20101&VW=T"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01625.x"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000179477.59385.93"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5992.320"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7121.1504"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2008.01742.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2008.01742.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T08:52:43Z","timestamp":1697273563000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2008.01742.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,29]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["10.1111\/j.1537-2995.2008.01742.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2008.01742.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,29]]}}}